Global Lung FLuid Status Monitor Market Size By Type (Invasive, Non-invasive), By Application (Hospitals, Other Medical Institutions), By Region, And Segment Forecasts, 2023 to 2032

The Global Lung Fluid Status Monitor Market was valued at USD 312 million in 2023 and is projected to surpass USD 768 million by 2031, growing at a CAGR of 12.0% during the forecast period of 2023–2031. The market growth is primarily driven by the increasing prevalence of cardiovascular and pulmonary diseases, especially congestive heart failure (CHF), and the rising need for non-invasive, real-time monitoring tools to prevent hospital readmissions. Lung fluid status monitors are gaining traction as crucial diagnostic and monitoring devices that help clinicians assess pulmonary congestion and guide fluid management strategies more accurately.

Drivers:

Rising Incidence of Heart Failure and Pulmonary Conditions:

Heart failure and related complications continue to be a leading cause of hospitalizations globally. Lung fluid monitoring offers a proactive solution to manage fluid overload in such patients, improving clinical outcomes and reducing healthcare costs.

Technological Advancements in Non-Invasive Monitoring:

Advancements in bioimpedance, ultrasound, and wearable sensor technologies have enhanced the accuracy, convenience, and adoption of lung fluid status monitors in clinical and home settings.

Demand for Remote Patient Monitoring (RPM):

The shift toward telehealth and remote patient monitoring is fostering the integration of lung fluid monitors into chronic disease management programs, especially for high-risk heart failure patients.

Restraints:

High Cost of Devices and Implementation:

Despite the benefits, the high cost associated with lung fluid status monitoring systems can be a barrier to adoption, particularly in cost-sensitive markets and smaller healthcare settings.

Limited Awareness Among Primary Care Providers:

In several developing regions, limited knowledge and training on lung fluid monitoring techniques hinder widespread adoption, especially outside major hospital systems.

Opportunity:

Integration with Digital Health Platforms:

The integration of lung fluid monitors with electronic health records (EHRs) and mobile health applications is expected to streamline data sharing, enable predictive analytics, and enhance patient engagement.

Untapped Markets in Asia-Pacific and Latin America:

Rapid urbanization, improving healthcare infrastructure, and rising healthcare spending are creating lucrative opportunities in emerging economies where heart failure and chronic diseases are on the rise.

Market by System Type Insights:

The market is segmented into Bioimpedance-based Monitors, Ultrasound-based Monitors, and Wearable Sensor Devices.

Among these, the Bioimpedance-based Monitors segment accounted for the largest share in 2023 due to their proven clinical utility, ease of use, and ability to detect early fluid accumulation. However, the Wearable Sensor Devices segment is projected to grow at the highest CAGR, fueled by patient preference for non-invasive, continuous monitoring and increasing adoption in home healthcare.

Market by End-use Insights:

Based on end-use, the market is divided into Hospitals & Clinics, Homecare Settings, and Ambulatory Surgical Centers.

In 2023, the Hospitals & Clinics segment held the largest market share, driven by increasing admissions related to fluid overload and growing reliance on in-hospital monitoring. However, the Homecare Settings segment is expected to experience significant growth during the forecast period, supported by rising demand for remote monitoring solutions and the shift toward patient-centered care.

Market by Regional Insights:

North America dominated the global lung fluid status monitor market in 2023, accounting for the largest market share, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high prevalence of heart failure.

Asia-Pacific is expected to be the fastest-growing region through 2031, propelled by rising cardiovascular disease burden, increasing healthcare investments, and greater awareness among healthcare professionals and patients.

Competitive Scenario:

Key players in the global lung fluid status monitor market include Abbott Laboratories, Sensible Medical Innovations, ZOLL Medical Corporation, Impedimed Ltd, Medtronic, Baxter International Inc., GE Healthcare, Philips Healthcare, CardiacSense Ltd., and RenalSense Ltd.

These companies are actively engaged in product development, regulatory approvals, partnerships, and technological integration.

In 2023, Sensible Medical received expanded FDA clearance for its ReDS™ system to be used in home settings.

In 2024, Abbott launched a next-gen wearable lung fluid monitor featuring AI-driven fluid overload prediction algorithms.

Scope of Work – Global Lung Fluid Status Monitor Market

Report Metric Details

Market Size (2023) USD 312 million

Projected Market Size (2031) USD 768 million

CAGR (2023–2031) 12.0%

Market Segments By System Type, End-Use, Region

Growth Drivers Rising heart failure prevalence, remote monitoring trend

Opportunities Wearable sensors, digital health integration

Key Market Developments:

2023: Sensible Medical's ReDS™ received approval for home-based fluid monitoring, marking a key milestone in remote care.

2024: Impedimed launched a new generation of bioimpedance monitors integrated with cloud analytics for heart failure patients.

2025: GE Healthcare announced strategic collaboration with a digital health startup to embed lung fluid data in virtual care platforms.

FAQs:

1) What is the current market size of the Global Lung Fluid Status Monitor Market?

The market was valued at USD 312 million in 2023.

2) What is the major growth driver of the Global Lung Fluid Status Monitor Market?

The increasing prevalence of heart failure and the demand for non-invasive, real-time fluid monitoring are key drivers.

3) Which is the largest region during the forecast period in the Global Lung Fluid Status Monitor Market?

North America is expected to retain the largest market share through the forecast period.

4) Which segment accounted for the largest market share in Global Lung Fluid Status Monitor Market?

The Bioimpedance-based Monitors segment led the market in 2023.

5) Who are the key market players in the Global Lung Fluid Status Monitor Market?

Abbott Laboratories, Sensible Medical Innovations, ZOLL Medical Corporation, Impedimed Ltd, Medtronic, GE Healthcare, among others.

Let me know if you'd like this in a Word format or need infographics or visuals for your report!